| Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia T Bhatla, J Wang, DJ Morrison, EA Raetz, MJ Burke, P Brown, WL Carroll Blood, The Journal of the American Society of Hematology 119 (22), 5201-5210, 2012 | 169 | 2012 |
| Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? EA Raetz, T Bhatla Hematology 2010, the American Society of Hematology Education Program Book …, 2012 | 131 | 2012 |
| Characterization of COVID‐19 disease in pediatric oncology patients: the New York‐New Jersey regional experience PP Madhusoodhan, J Pierro, J Musante, P Kothari, B Gampel, B Appel, ... Pediatric Blood & Cancer 68 (3), e28843, 2021 | 112 | 2021 |
| Progress and prospects in pediatric leukemia PP Madhusoodhan, WL Carroll, T Bhatla Current problems in pediatric and adolescent health care 46 (7), 229-241, 2016 | 108 | 2016 |
| MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia CL Jones, CM Gearheart, S Fosmire, C Delgado-Martin, NA Evensen, ... Blood, The Journal of the American Society of Hematology 126 (19), 2202-2212, 2015 | 100 | 2015 |
| Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia S Dandekar, E Romanos‐Sirakis, F Pais, T Bhatla, C Jones, W Bourgeois, ... British journal of haematology 167 (1), 87-99, 2014 | 80 | 2014 |
| Epigenetic modifications in pediatric acute lymphoblastic leukemia MJ Burke, T Bhatla Frontiers in pediatrics 2, 42, 2014 | 71 | 2014 |
| Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model CL Jones, T Bhatla, R Blum, J Wang, SW Paugh, X Wen, W Bourgeois, ... Journal of Biological Chemistry 289 (30), 20502-20515, 2014 | 70 | 2014 |
| Endogenous knockdown of survivin improves chemotherapeutic response in ALL models DJ Morrison, LE Hogan, G Condos, T Bhatla, N Germino, NP Moskowitz, ... Leukemia 26 (2), 271-279, 2012 | 60 | 2012 |
| New targeted therapies for relapsed pediatric acute lymphoblastic leukemia J Pierro, LE Hogan, T Bhatla, WL Carroll Expert review of anticancer therapy 17 (8), 725-736, 2017 | 56 | 2017 |
| The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions T Bhatla, CL Jones, JA Meyer, NA Vitanza, EA Raetz, WL Carroll Journal of pediatric hematology/oncology 36 (6), 413-418, 2014 | 54 | 2014 |
| Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis—case report and review of the literature NC Arva, JG Pappas, T Bhatla, EA Raetz, M Macari, HB Ginsburg, ... The American Journal of Surgical Pathology 36 (1), 149-153, 2012 | 54 | 2012 |
| MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia NA Evensen, PP Madhusoodhan, J Meyer, J Saliba, A Chowdhury, ... haematologica 103 (5), 830, 2018 | 46 | 2018 |
| Acute lymphoblastic leukemia WL Carroll, T Bhatla Lanzkowsky's manual of pediatric hematology and oncology, 367-389, 2016 | 37 | 2016 |
| Ikaros deletions in BCR–ABL‐negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance NA Vitanza, W Zaky, R Blum, JA Meyer, J Wang, T Bhatla, DJ Morrison, ... Pediatric blood & cancer 61 (10), 1779-1785, 2014 | 37 | 2014 |
| Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples BY Lu, SU Thanawala, KC Zochowski, MJ Burke, WL Carroll, T Bhatla Leukemia & Lymphoma 57 (8), 1938-1941, 2016 | 33 | 2016 |
| Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic … LE Hogan, T Bhatla, DT Teachey, FJB Sirvent, J Moppett, PV Puyó, ... Journal of Clinical Oncology 40 (16_suppl), 10001-10001, 2022 | 26 | 2022 |
| Children's Oncology Group AALL1331: phase III trial of blinatumomab in children, adolescents, and young adults with low-risk B-cell ALL in first relapse LE Hogan, PA Brown, L Ji, X Xu, M Devidas, T Bhatla, MJ Borowitz, ... Journal of Clinical Oncology 41 (25), 4118-4129, 2023 | 25 | 2023 |
| Bilateral parotid gland enlargement and palpable nephromegaly in infant acute lymphoblastic leukemia: Case report and review of the literature A Saha, S Dandekar, S Milla, E Roman, T Bhatla Journal of pediatric hematology/oncology 36 (3), 246-248, 2014 | 23 | 2014 |
| A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in Low Risk (LR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and … PA Brown, L Ji, X Xu, M Devidas, L Hogan, T Bhatla, M Borowitz, ... Blood 138, 363, 2021 | 14 | 2021 |
